Lipid Nanomaterials-Based RNA Therapy and Cancer Treatment

Xingcai Zhang,Luo Hai,Yibo Gao,Guocan Yu,Yingli Sun

DOI: https://doi.org/10.1016/j.apsb.2022.10.004

IF: 14.903

2022-01-01

Acta Pharmaceutica Sinica B

Abstract:We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology.